Du Xin

Du Xin

Du Xin, female, member of the Communist Party of China. Director of Guangdong Provincial People's Hospital, master tutor. He graduated from Lanzhou Medical College in 1989 with a master's degree in hematology. He is a part-time professor in Medical College of Sun Yat sen University, Southern Medical University and Shantou University.

Personage introduction

Assigned to Guangdong Provincial People's hospital. In 1998, he was the director of Hematology Department of Guangdong Provincial People's Hospital; in 2001, he received the doctor's degree of pathophysiology from Sun Yat Sen Medical University; in 2002, he was the chief physician of Hematology Department. From 2004 to 2005, he went to M. D. Anderson Cancer Center in Houston, USA for academic exchange. At present, he is vice chairman of the Sixth Committee of Hematology Society of Guangdong Medical Association, member of the first lymphoma Professional Committee of Guangdong anti cancer association, member of the Second Committee of Hematology tumor Professional Committee of Guangdong anti cancer association, vice chairman of the third hematology tumor Professional Committee of Guangzhou anti cancer association, member of the first committee of organ transplantation branch of Guangdong Medical Association, member of Guangzhou anti cancer association Vice chairman of the first committee of Hematology Professional Committee of the East provincial society of integrated traditional Chinese and Western medicine. Editorial board member of International Journal of blood transfusion and hematology, evidence based medicine and Chinese Journal of practical medicine.

work experience

He has been engaged in hematology for more than 20 years, and has accumulated rich experience in the diagnosis and treatment of blood tumors, and carried out a number of related research. The main research direction is comprehensive diagnosis and treatment of hematological tumors and hematopoietic stem cell transplantation, focusing on the problems urgently needed to be solved in clinical diagnosis and treatment, such as diagnosis and treatment of difficult hematological diseases, treatment of senile leukemia and myelodysplastic syndrome and analysis of prognostic factors. On the other hand, we have carried out in-depth research on graft-versus-host disease (GVHD), which mainly affects the long-term survival and quality of life of patients after allogeneic hematopoietic stem cell transplantation. At present, we have carried out relevant research work in the field of prevention and treatment of GVHD with mesenchymal stem cells (MSc), and are carrying out research on the clinical application and related mechanism of MSc in the treatment of GVHD. In recent years, he has published more than 30 articles and undertaken 15 projects, including one National Natural Science Research Fund, one national 863 research fund, one Guangdong Natural Science Research Fund, two joint medical and health research projects of Guangdong science and technology department and health department, and one major science and technology project of Guangzhou. He won the second prize of science and technology progress of Guangdong Province in 2001, the second prize of science and technology achievements of the Ministry of education in 2002, the third prize of science and technology progress of Guangdong Province in 2003 and the second prize of science and technology progress of Guangzhou City in 2004.